|
Louis A. Tartaglia, Ph.D. was appointed Chief Scientific Officer in February 2007. Prior to that appointment, he served as Senior Vice President and General Manager, Drug Repositioning and Selection beginning in January 2005. Dr. Tartaglia joined Gene Logic in July 2004 following Gene Logic's acquisition of certain technologies from Millennium Pharmaceuticals, Inc. From 2002 to 2004, Dr. Tartaglia served as Vice President of New Ventures at Millennium Pharmaceuticals, Inc. From 1999 to 2002, he served as Vice President of Metabolic Diseases. Dr. Tartaglia holds a Ph.D. in Biochemistry from the University of California, Berkeley. | 